Search for Clinical Trial Results
Polycystic Kidney Diseases - 25 Studies Found
Status | Study |
Completed |
Study Name: 8-Week Study of Tolvaptan Dose Forms in Autosomal Dominant Polycystic Kidney Disease (ADPKD) Condition: Autosomal Dominant Polycystic Kidney Disease Date: 2011-10-11 Interventions:
|
Not yet recruiting |
Study Name: A Randomised Feasibility Trial of High Water Intake in Polycystic Kidney Disease Condition: Autosomal Dominant Polycystic Kidney Disease Date: 2016-09-18 Interventions:
|
Completed |
Study Name: Efficacy, Safety and Tolerability of Everolimus in Preventing End-stage Renal Disease in Patients With Autosomal Dominant Polycystic Kidney Disease Condition: Autosomal Dominant Polycystic Kidney Disease Date: 2006-12-20 Interventions:
|
Active, not recruiting |
Study Name: Somatostatin In Patients With Autosomal Dominant Polycystic Kidney Disease And Moderate To Severe Renal Insufficiency Condition: Autosomal Dominant Polycystic Kidney Disease Date: 2011-06-20 Interventions:
|
Completed |
Study Name: Sirolimus (Rapamune®) for Autosomal Dominant Polycystic Kidney Disease (ADPKD) Condition: Autosomal Dominant Polycystic Kidney Disease (ADPKD) Date: 2006-06-22 Interventions:
|
Recruiting |
Study Name: The Efficacy of Everolimus in Reducing Total Native Kidney Volume in Polycystic Kidney Disease Transplanted Recipients Condition: Autosomal Dominant Polycystic Kidney Disease Date: 2014-04-28 Interventions:
|
Recruiting |
Study Name: Use of Low Dose Pioglitazone to Treat Autosomal Dominant Polycystic Kidney Disease Condition: Polycystic Kidney Disease Date: 2015-10-30 Interventions:
|
Completed |
Study Name: Water as Therapy in Autosomal Dominant Polycystic Kidney Disease (ADPKD) Condition: Autosomal Dominant Polycystic Kidney Disease Date: 2008-09-24 Interventions: Other: Water prescription Water prescription in 12 to 16 equally divided doses |
Terminated |
Study Name: Sirolimus In Autosomal Dominant Polycystic Kidney Disease And Severe Renal Insufficiency Condition: Autosomal Dominant Polycystic Kidney Disease (ADPKD) Date: 2010-10-12 Interventions:
|
Completed |
Study Name: A Long-term Administration Study of OPC-41061 in Patients With Autosomal Dominant Polycystic Kidney Disease (ADPKD) [Extension of Study 156-04-001] Condition: Autosomal Dominant Polycystic Kidney Disease Date: 2009-02-09 Interventions: Drug: OPC-41061 orally administered at 15 mg twice daily (morning and evening) for a maximum of 3 years. |